Aberrant Expression of NF-κB in Liver Fluke Associated Cholangiocarcin
- This topic has 0 replies, 1 voice, and was last updated 9 years, 10 months ago by
.
Viewing 1 post (of 1 total)
-
Posts
-
Aberrant Expression of NF-κB in Liver Fluke Associated Cholangiocarcinoma: Implications for Targeted Therapy.
“NF-κB was over-expressed in CCA tissues. Inhibition of NF-κB action significantly reduced cell growth and enhanced cell apoptosis. This study highlights NF-κB as a molecular target for CCA therapy.”
http://www.ncbi.nlm.nih.gov/pubmed/25170898
Viewing 1 post (of 1 total)
- The forum ‘New Developments’ is closed to new topics and replies.